Loading…
Specific and redundant roles of PKBα/AKT1 and PKBβ/AKT2 in human pancreatic islets
Protein kinase Bα (PKBα)/AKT1 and PKBβ/AKT2 are required for normal peripheral insulin action but their role in pancreatic β cells remains enigmatic as indicated by the relatively mild islet phenotype of mice with deficiency for either one of these two isoforms. In this study we have analysed prolif...
Saved in:
Published in: | Experimental cell research 2015-10, Vol.338 (1), p.82-88 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Protein kinase Bα (PKBα)/AKT1 and PKBβ/AKT2 are required for normal peripheral insulin action but their role in pancreatic β cells remains enigmatic as indicated by the relatively mild islet phenotype of mice with deficiency for either one of these two isoforms. In this study we have analysed proliferation, apoptosis, β cell size and glucose-stimulated insulin secretion in human islets overexpressing either PKBα or PKBβ. Our results reveal redundant and specific functions. Overexpression of either isoform resulted in increased β cell size, but insulin production and secretion remained unchanged. Proliferation and apoptosis of β cells were only significantly stimulated and inhibited, respectively, by PKBα/AKT1. Importantly, overexpression of PKBα/AKT1 in dissociated islets increased the ratio of β cells to non-β cells. These results confirm our previous findings obtained with rodent islets and strongly indicate that PKBα/AKT1 can regulate β cell mass also in human islets.
•PKBα and PKBβ have specific but also redundant functions in human pancreatic islets.•Only PKBα drives islet and β cell proliferation.•Only PKBα protects β cells and islets from apoptosis.•Both isoforms can increase β cell size.•Regulation of islet mass seems to be conserved between rodent and human. |
---|---|
ISSN: | 0014-4827 1090-2422 |
DOI: | 10.1016/j.yexcr.2015.08.008 |